Free Trial

Harvard Bioscience (HBIO) Short Interest Ratio & Short Volume

Harvard Bioscience logo
$2.40
+0.05 (+2.13%)
(As of 11/1/2024 ET)

Harvard Bioscience Short Interest Data

Harvard Bioscience (HBIO) has a short interest of 350,600 shares. This marks a 11.41% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.2, indicating that it would take 3.2 days of the average trading volume of 113,396 shares to cover all short positions.

Current Short Interest
350,600 shares
Previous Short Interest
314,700 shares
Change Vs. Previous Month
+11.41%
Dollar Volume Sold Short
$858,970.00
Short Interest Ratio
3.2 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
43,610,000 shares
Percentage of Shares Shorted
0.80%
Today's Trading Volume
51,908 shares
Average Trading Volume
113,396 shares
Today's Volume Vs. Average
46%
Short Selling Harvard Bioscience?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Harvard Bioscience and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HBIO Short Interest Over Time

HBIO Days to Cover Over Time

HBIO Percentage of Float Shorted Over Time

Harvard Bioscience Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024350,600 shares $858,970.00 +11.4%N/A3.2 $2.45
9/30/2024314,700 shares $846,543.00 -26.7%N/A2.8 $2.69
9/15/2024429,100 shares $1.24 million +0.6%N/A3.3 $2.88
8/31/2024426,600 shares $1.23 million -0.1%1.1%2.9 $2.88
8/15/2024426,800 shares $1.22 million -4.4%1.1%2.8 $2.86
7/31/2024446,500 shares $1.43 million +3.7%1.1%3 $3.20
7/15/2024430,700 shares $1.43 million -19.4%1.1%2.8 $3.32
6/30/2024534,400 shares $1.52 million +38.4%1.3%3.6 $2.85
6/15/2024386,200 shares $1.12 million -16.3%1.0%3.1 $2.90
5/31/2024461,500 shares $1.46 million -25.6%N/A3.9 $3.17
5/15/2024620,100 shares $2.14 million -9.0%N/A6.5 $3.45
4/30/2024681,200 shares $2.60 million +1.2%N/A7.5 $3.82
4/15/2024673,000 shares $2.99 million +5.7%N/A7.7 $4.44
3/31/2024636,700 shares $2.70 million -11.2%N/A7.6 $4.24
3/15/2024716,600 shares $2.90 million +0.5%N/A8.5 $4.05
2/29/2024712,900 shares $3.09 million -3.4%1.8%8.4 $4.33
2/15/2024738,300 shares $3.59 million -6.5%1.9%8.5 $4.86
1/31/2024789,400 shares $3.47 million -8.8%2.0%9.1 $4.40
1/15/2024865,500 shares $4.24 million -4.8%2.2%9.9 $4.90
12/31/2023909,500 shares $4.87 million +3.1%2.3%10.6 $5.35
12/15/2023881,900 shares $4.32 million -7.6%2.2%10.1 $4.90
11/30/2023954,600 shares $4.07 million -10.8%2.4%10.7 $4.26
11/15/20231,070,000 shares $4.55 million +5.9%2.7%11.8 $4.25
10/31/20231,010,000 shares $4.43 million -2.9%2.6%9.6 $4.39
10/15/20231,040,000 shares $4.31 million -1.0%2.6%8.4 $4.14
9/30/20231,050,000 shares $4.52 million +13.0%2.7%7.7 $4.30
9/15/2023928,900 shares $4.23 million -3.7%2.3%5.8 $4.55
8/31/2023964,800 shares $4.25 million -1.9%2.4%3.7 $4.41
8/15/2023983,800 shares $4.17 million +0.6%2.5%3.5 $4.24
7/31/2023978,300 shares $4.55 million -4.1%2.5%3.3 $4.65
7/15/20231,020,000 shares $5.57 million -1.9%2.6%3.3 $5.46
6/30/20231,040,000 shares $5.71 million +221.3%2.7%3.2 $5.49
6/15/2023323,700 shares $1.76 million -16.5%0.8%1 $5.44
5/31/2023387,500 shares $2.17 million +0.2%1.0%1.8 $5.59
5/15/2023386,700 shares $2.06 million +10.9%1.0%2.2 $5.34
4/30/2023348,800 shares $2.00 million +28.1%1.0%2.3 $5.72
4/15/2023272,200 shares $1.34 million -7.6%0.8%2.5 $4.93
3/31/2023294,700 shares $1.24 million +14.9%0.8%3.1 $4.20
3/15/2023256,400 shares $676,896.00 -1.8%0.7%2.4 $2.64
2/28/2023261,100 shares $738,913.00 -1.3%0.7%2.3 $2.83
True paradigm shift (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

2/15/2023264,500 shares $812,015.00 +1.7%0.7%2.3 $3.07
1/31/2023260,000 shares $774,800.00 -2.1%0.7%1.9 $2.98
1/15/2023265,600 shares $778,208.00 -32.6%0.7%1.9 $2.93
12/30/2022394,100 shares $1.09 million +22.9%1.1%2.8 $2.77
12/15/2022320,600 shares $769,440.00 +9.4%0.9%2.1 $2.40
11/30/2022293,200 shares $750,592.00 +5.6%0.8%2.6 $2.56
11/15/2022277,700 shares $666,480.00 +8.1%0.8%2.6 $2.40
10/31/2022256,800 shares $690,792.00 -6.3%0.7%2.4 $2.69
10/15/2022274,100 shares $619,466.00 +2.5%0.8%2.3 $2.26
9/30/2022267,400 shares $684,544.00 +3.6%0.7%2.1 $2.56
9/15/2022258,200 shares $800,420.00 -5.6%0.7%1.3 $3.10
8/31/2022273,500 shares $902,550.00 -5.8%0.8%1.2 $3.30
8/15/2022290,300 shares $937,669.00 -8.0%0.8%1.1 $3.23
7/31/2022315,400 shares $1.19 million -13.8%0.9%1.1 $3.76
7/15/2022365,700 shares $1.33 million -21.2%1.0%1.2 $3.65
6/30/2022464,000 shares $1.67 million -72.1%1.4%1.5 $3.60
6/15/20221,660,000 shares $6.09 million +5.7%5.1%5.3 $3.67
5/31/20221,570,000 shares $5.75 million -1.3%4.3%7.1 $3.66
5/15/20221,590,000 shares $6.01 million +30.3%4.4%8.1 $3.78
4/30/20221,220,000 shares $6.37 million +11.9%3.3%6.7 $5.22
4/15/20221,090,000 shares $6.41 million +1.9%3.0%7.1 $5.88
3/31/20221,070,000 shares $6.64 million +7.0%2.9%7 $6.21
3/15/2022999,600 shares $5.89 million +24.6%2.7%6.6 $5.89
2/28/2022802,600 shares $4.33 million +2.7%2.2%5 $5.40
2/15/2022781,500 shares $4.29 million +20.1%2.1%4.9 $5.49
1/31/2022650,700 shares $3.79 million +9.4%1.8%4.2 $5.82
1/15/2022594,700 shares $3.60 million -2.1%N/A0 $6.06
12/31/2021607,700 shares $4.28 million +19.5%1.7%3.8 $7.05
12/15/2021508,500 shares $3.53 million -0.3%1.4%3 $6.94
11/30/2021509,900 shares $3.41 million +0.5%1.4%3.2 $6.69
11/15/2021507,200 shares $3.94 million -16.4%1.4%3.1 $7.77
10/29/2021606,400 shares $4.57 million +5.6%1.7%3.4 $7.53
10/15/2021574,000 shares $3.93 million -10.9%1.6%3.2 $6.84
9/30/2021644,000 shares $4.50 million -5.1%1.8%3.5 $6.98
9/15/2021678,300 shares $5.32 million +0.6%1.9%3.2 $7.84
8/31/2021674,400 shares $5.57 million +1.7%1.9%3.1 $8.26
8/13/2021663,300 shares $5.61 million +2.7%1.8%2.9 $8.46
7/30/2021646,200 shares $5.10 million -9.6%1.8%2.7 $7.89
7/15/2021715,100 shares $5.44 million +7.4%2.0%2.8 $7.61
6/30/2021665,800 shares $5.55 million -3.2%1.9%2.5 $8.33
6/15/2021688,000 shares $5.19 million -16.9%1.9%2.8 $7.55
5/28/2021828,000 shares $5.80 million -4.1%2.3%2.8 $7.00
5/14/2021863,600 shares $5.98 million +8.2%2.4%3.1 $6.92
4/30/2021798,200 shares $5.75 million -16.3%2.2%3.1 $7.20
4/15/2021953,700 shares $6.33 million +16.8%2.7%4.2 $6.64
3/31/2021816,500 shares $4.44 million +21.9%2.3%3.7 $5.44
3/15/2021669,800 shares $4.30 million +0.7%1.9%3.4 $6.42
2/26/2021665,100 shares $2.88 million +4.6%2.0%5.2 $4.33
2/12/2021636,100 shares $2.98 million -1.8%1.8%5.3 $4.69
1/29/2021647,900 shares $2.93 million +5.5%1.9%5 $4.52
True paradigm shift (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

1/15/2021614,300 shares $2.55 million -0.1%1.8%4.7 $4.15
12/31/2020615,000 shares $2.63 million +5.2%1.8%5.2 $4.27
12/15/2020584,400 shares $2.48 million -7.7%1.7%4.9 $4.24
11/30/2020632,900 shares $2.45 million -11.1%1.8%5.3 $3.87
11/15/2020711,600 shares $2.88 million -44.8%2.1%5.9 $4.05
10/30/20201,290,000 shares $4.26 million -5.2%3.8%11.9 $3.30
10/15/20201,360,000 shares $4.43 million No Change4.0%11.8 $3.26
9/30/20201,360,000 shares $4.09 million -3.6%4.0%0 $3.01
9/15/20201,410,000 shares $4.53 million -0.7%4.1%5.4 $3.21
8/31/20201,420,000 shares $4.76 million -4.1%4.1%4.7 $3.35
8/14/20201,480,000 shares $5.42 million No Change4.3%4.7 $3.66
7/31/20201,480,000 shares $4.60 million +2.1%4.4%4.5 $3.11
7/15/20201,450,000 shares $4.89 million -40.8%4.3%4.2 $3.37
6/30/20202,450,000 shares $7.60 million +64.4%7.2%6.9 $3.10
6/15/20201,490,000 shares $4.05 million +41.9%4.4%6.4 $2.72
5/29/20201,050,000 shares $2.77 million +5.0%3.1%5.1 $2.64
5/15/20201,000,000 shares $2.58 million -9.1%2.9%4.6 $2.58
4/30/20201,100,000 shares $3.03 million +79.1%3.2%5.5 $2.75
4/15/2020614,300 shares $1.65 million -7.2%1.8%3.5 $2.68
3/31/2020662,100 shares $1.77 million -1.5%1.9%4.7 $2.68
3/13/2020672,400 shares $1.67 million +1.9%2.0%3.6 $2.48
2/28/2020659,700 shares $1.13 million +4.4%1.9%6.6 $1.71
2/14/2020632,100 shares $1.68 million -1.0%1.9%8 $2.65
1/31/2020638,200 shares $1.89 million +2.1%1.9%7.4 $2.96
1/15/2020625,200 shares $1.73 million -4.6%1.8%7.2 $2.76
12/31/2019655,100 shares $1.97 million -1.1%1.9%7.9 $3.00

HBIO Short Interest - Frequently Asked Questions

What is Harvard Bioscience's current short interest?

Short interest is the volume of Harvard Bioscience shares that have been sold short but have not yet been covered or closed out. As of October 15th, traders have sold 350,600 shares of HBIO short. Learn More on Harvard Bioscience's current short interest.

What is a good short interest ratio for Harvard Bioscience?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HBIO shares currently have a short interest ratio of 3.0. Learn More on Harvard Bioscience's short interest ratio.

Is Harvard Bioscience's short interest increasing or decreasing?

Harvard Bioscience saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 350,600 shares, an increase of 11.4% from the previous total of 314,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Harvard Bioscience's short interest compare to its competitors?

Here is how the short interest of companies compare to Harvard Bioscience: Accelerate Diagnostics, Inc. (3.41%), Thermo Fisher Scientific Inc. (0.80%), Agilent Technologies, Inc. (1.13%), Mettler-Toledo International Inc. (1.34%), Illumina, Inc. (4.26%), Waters Co. (3.93%), Bio-Techne Co. (2.27%), Charles River Laboratories International, Inc. (4.09%), Bio-Rad Laboratories, Inc. (4.32%), Bruker Co. (4.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short Harvard Bioscience stock?

Short selling HBIO is an investing strategy that aims to generate trading profit from Harvard Bioscience as its price is falling. HBIO shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Harvard Bioscience?

A short squeeze for Harvard Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HBIO, which in turn drives the price of the stock up even further.

How often is Harvard Bioscience's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HBIO, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:HBIO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners